Bone Biologics Corp (BBLG) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$5.7K2011: -$3.6K2012: -$6.1K2013: -$525.4K2014: -$2.76M2015: -$3.55M2016: -$7.33M2017: -$3.33M2018: -$4.10M2019: -$3.25M2020: -$426.9K2021: -$1.23M2022: -$3.57M2023: -$9.56M2024: -$4.12M2025: -$2.69M-$2.69M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.69M+34.8%
2024-$4.12M+56.8%
2023-$9.56M-167.9%
2022-$3.57M-190.3%
2021-$1.23M-187.8%
2020-$426.9K+86.9%
2019-$3.25M+20.8%
2018-$4.10M-23.3%
2017-$3.33M+54.6%
2016-$7.33M-106.7%
2015-$3.55M-28.7%
2014-$2.76M-424.5%
2013-$525.4K-8573.7%
2012-$6.1K-68.4%
2011-$3.6K+36.7%
2010-$5.7K